{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:46:26Z","timestamp":1792431986296,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"am","delay-in-days":277,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.resmer.2025.101186","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T12:33:40Z","timestamp":1750077220000},"page":"101186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Use of complementary medicines and self-medication practices in cystic fibrosis \u2013 MUCAUTOMED study"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6914-7951","authenticated-orcid":false,"given":"Sophie","family":"Lemagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"R\u00e9coch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5726-8815","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Eyvrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remy","family":"Chambault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Mittaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2881-2740","authenticated-orcid":false,"given":"Marl\u00e8ne","family":"Murris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.resmer.2025.101186_bib0001","doi-asserted-by":"crossref","first-page":"402\u20116","DOI":"10.1016\/j.jcf.2019.09.018","article-title":"Adherence to lumacaftor-ivacaftor therapy in patients with cystic fibrosis in France","volume":"19","author":"Olivereau","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.resmer.2025.101186_bib0002","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3390\/pharmaceutics14081674","article-title":"Therapeutic drug monitoring of ivacaftor, lumacaftor, tezacaftor, and elexacaftor in cystic fibrosis: where are we now?","volume":"14","author":"Choong","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.resmer.2025.101186_bib0003","doi-asserted-by":"crossref","first-page":"478\u201183","DOI":"10.1016\/j.jcf.2023.01.005","article-title":"Drug-drug interactions with CFTR modulator therapy in cystic fibrosis: focus on Trikafta\u00ae\/Kaftrio\u00ae","volume":"22","author":"Purkayastha","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resmer.2025.101186_bib0004","unstructured":"Vaincre la Mucoviscidose. 2015 [cited 2022 mars 24]. Registre fran\u00e7ais de la mucoviscidose. Available from: https:\/\/www.vaincrelamuco.org\/registredelamuco"},{"issue":"5","key":"10.1016\/j.resmer.2025.101186_bib0005","doi-asserted-by":"crossref","first-page":"171\u20115","DOI":"10.18773\/austprescr.2022.063","article-title":"Drug treatment of cystic fibrosis","volume":"45","author":"Bruorton","year":"2022","journal-title":"Aust Prescr"},{"key":"10.1016\/j.resmer.2025.101186_sbref0006","series-title":"Strat\u00e9gie de l\u2019OMS pour la m\u00e9decine traditionnelle pour 2014-2023","year":"2013"},{"issue":"5","key":"10.1016\/j.resmer.2025.101186_bib0007","doi-asserted-by":"crossref","first-page":"479\u201191","DOI":"10.1016\/j.bulcan.2019.02.011","article-title":"Les m\u00e9decines alternatives compl\u00e9mentaires en oncologie","volume":"106","author":"Bosacki","year":"2019","journal-title":"Bull Cancer"},{"key":"10.1016\/j.resmer.2025.101186_bib0008","unstructured":"La France, second pays producteur d\u2019huiles essentielles de l\u2019union Europ\u00e9enne - insee focus - 266. [cited 2023 may 8]. Available from: https:\/\/www.insee.fr\/fr\/statistiques\/6434102"},{"issue":"1","key":"10.1016\/j.resmer.2025.101186_bib0009","first-page":"27\u201132","article-title":"Complementary and alternative medicine: a survey of its use in children with chronic respiratory illness","volume":"50","author":"Richmond","year":"2014","journal-title":"Can J Respir Ther"},{"key":"10.1016\/j.resmer.2025.101186_sbref0010","series-title":"The use of complementary and alternative medicine among pediatric cystic fibrosis patients","author":"Tanase","year":"2009"},{"key":"10.1016\/j.resmer.2025.101186_bib0011","doi-asserted-by":"crossref","first-page":"68\u201174","DOI":"10.1016\/j.ctcp.2016.08.006","article-title":"Complementary and alternative medicine use in children with cystic fibrosis","volume":"25","author":"Giangioppo","year":"2016","journal-title":"Complement Ther Clin Pract"},{"key":"10.1016\/j.resmer.2025.101186_bib0012","unstructured":"Mercan A., Souard F. Usages des huiles essentielles par les patients atteints de mucoviscidose. Communication orale. 16\u00e8mes journ\u00e9es scientifiques de la mucoviscidose. Unpublished Results; 2023; Paris."},{"key":"10.1016\/j.resmer.2025.101186_bib0013","series-title":"The role of the pharmacist in self-care and self-medication. Report of the 4th WHO consultative group on the Role of the pharmacist","year":"1998"},{"key":"10.1016\/j.resmer.2025.101186_bib0014","unstructured":"De l\u2019autodiagnostic \u00e0 l\u2019autom\u00e9dication : risques et impact sur la relation pharmacien-patient \u2013 Acad\u00e9mie nationale de m\u00e9decine. [cited 2022 jul 12]. Available from: https:\/\/www.academie-medecine.fr\/de-lautodiagnostic-a-lautomedication-risques-et-impact-sur-la-relation-pharmacien-patient\/"},{"key":"10.1016\/j.resmer.2025.101186_bib0015","article-title":"Soci\u00e9t\u00e9 Fran\u00e7aise de pharmacie oncologique. recommandations et publications SFPO","year":"2015","journal-title":"Soci\u00e9t\u00e9 Fran\u00e7aise De Pharmacie Oncologique"},{"key":"10.1016\/j.resmer.2025.101186_bib0017","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/S1569-1993(06)80347-4","article-title":"407 Survey on complementary and alternative medicine in French patients with Cystic Fibrosis. Abstract. 29th European Cystic Fibrosis Conference; 2006 Jun 15-18; Copenhagen, Denmark","volume":"5","author":"Agrario","year":"2006","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.resmer.2025.101186_bib0018","first-page":"196\u2011200","article-title":"Phytotherapy and antiretrovirals: actions lead in a therapeutic education progam for patients living with HIV","volume":"38","author":"Combe","year":"2019","journal-title":"J Pharm Clin"},{"key":"10.1016\/j.resmer.2025.101186_bib0019","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3389\/fonc.2019.01356","article-title":"Herbal interaction with chemotherapeutic drugs\u2014a focus on clinically significant findings","volume":"9","author":"Fasinu","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.resmer.2025.101186_bib0020","unstructured":"HEDRINE ULB. [cited 2023 may 8]. Available from: https:\/\/hedrine.ulb.be\/"},{"issue":"6","key":"10.1016\/j.resmer.2025.101186_bib0021","doi-asserted-by":"crossref","first-page":"1061\u20115","DOI":"10.1016\/j.jcf.2022.05.001","article-title":"Dose adjustments of Elexacaftor\/Tezacaftor\/Ivacaftor in response to mental health side effects in adults with cystic fibrosis","volume":"21","author":"Spoletini","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.resmer.2025.101186_bib0022","doi-asserted-by":"crossref","first-page":"343\u201154","DOI":"10.1016\/j.psym.2017.04.001","article-title":"Cystic fibrosis transmembrane regulator modulators: implications for the management of depression and anxiety in cystic fibrosis","volume":"58","author":"Talwalkar","year":"2017","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1016\/j.resmer.2025.101186_bib0023","doi-asserted-by":"crossref","first-page":"525\u20117","DOI":"10.1016\/j.jcf.2017.05.008","article-title":"Worsening anxiety and depression after initiation of lumacaftor\/ivacaftor combination therapy in adolescent females with cystic fibrosis","volume":"16","author":"McKinzie","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resmer.2025.101186_bib0024","unstructured":"ANSM. [cited 2023 jul 3]. ATU\/RTU - Kaftrio - Kalydeco - Trikafta. Available from: https:\/\/ansm.sante.fr\/tableau-acces-derogatoire\/kaftrio-75-mg-50-mg-100-mg-comprime-pellicule-kalydeco-150-mg-comprime-pellicule"},{"key":"10.1016\/j.resmer.2025.101186_bib0025","unstructured":"Barth\u00e9l\u00e9my L. 2017. [cited 2023 aug 16]. Les Fran\u00e7ais et l\u2019autom\u00e9dication en premier recours : quelle place pour le professionnel de sant\u00e9 ? IPSOS survey. Available from: https:\/\/www.ipsos.com\/fr-fr\/les-francais-et-lautomedication-en-premier-recours-quelle-place-pour-le-professionnel-de-sante"},{"key":"10.1016\/j.resmer.2025.101186_bib0026","article-title":"Autom\u00e9dication des enfants de moins de 12 ans par leurs parents et risques encourus","volume":"60","author":"Escourrou","year":"2010","journal-title":"Suppl\u00e9ment La Revue Du Praticien"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:40:58Z","timestamp":1763829658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041225000339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":25,"alternative-id":["S2590041225000339"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101186","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of complementary medicines and self-medication practices in cystic fibrosis \u2013 MUCAUTOMED study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SPLF and Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101186"}}